SCHEMBL6771037

SCHEMBL6771037

Cn1cccc1C(=O)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
SMN1; SMN2 Q16637 4/20 0.56
HSD17B10 Q99714 1/20 0.56
KDM4E B2RXH2 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RORC P51449 7/20 0.49
MAPT P10636 5/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
LMNA P02545 2/20 0.49
MAPK1 P28482 2/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
PKM P14618 1/20 0.49
TSHR P16473 1/20 0.49
NFKB1 P19838 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7081998 0.90 SMN1; SMN2 (0.67) ALDH1A1SMN1; SMN2HSD17B10NPSR1MAPT
SCHEMBL10953243 0.80 HSD17B10 (0.62) ALDH1A1SMN1; SMN2HSD17B10KDM4ENPSR1
SCHEMBL6324751 0.77 SRD5A2 (0.51) ALDH1A1MAPTLMNAMAPK1TSHR
SCHEMBL7466939 0.77 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL9383327 0.76 RORC (0.61) ALDH1A1SMN1; SMN2HSD17B10KDM4ENPSR1
SCHEMBL6951515 0.75 SMN1; SMN2 (0.69) ALDH1A1SMN1; SMN2HSD17B10MAPTMEN1
SCHEMBL16922169 0.75 NPSR1 (0.64) ALDH1A1SMN1; SMN2KDM4ENPSR1RORC
SCHEMBL3661954 0.75 NPSR1 (0.64) ALDH1A1SMN1; SMN2KDM4ENPSR1RORC
SCHEMBL10902402 0.74 NPSR1 (0.71) ALDH1A1SMN1; SMN2HSD17B10KDM4ENPSR1
Acetic Acid SCHEMBL27779261 0.74 NPSR1 (0.63) ALDH1A1SMN1; SMN2KDM4ENPSR1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6706663-B2 CHEMICAL INTERMEDIATES WYETH 2004-03-16 US disclosed
EP-1274708-A1 HERBICIDAL 3-HETEROCYCLIC SUBSTITUTED BENZISOTHIAZOLE AND BENZISOXAZOLE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2003-01-15 EP disclosed
US-20020028748-A1 Herbicidal 3 -heterocyclic substituted benzisothiazole and benzisoxazole compounds INTELLECTUAL PROPERTY DEPARTMENT BASF AKTIENGESELLSCHAFT (DE) 2002-03-07 US disclosed
WO-2001079203-A1 HERBICIDAL 3-HETEROCYCLIC SUBSTITUTED BENZISOTHIAZOLE AND BENZISOXAZOLE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2001-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028748-A1 Herbicidal 3 -heterocyclic substituted benzisothiazole and benzisoxazole compounds CYP4X1, HAX1, DDT ALDH1A1 201/4885SMN1; SMN2 3446/4885HSD17B10 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.